Review
Accepted on 01 Apr 2025
Advances in the Effectiveness and Safety of Azvudine Treatment: A Comprehensive Review
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1524072
Type at least 3 characters
364 articles
Review
Published on 01 Apr 2025
Natural compounds: new therapeutic approach for inhibition of Streptococcus mutans and dental caries
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1548117
- 239 views
Original Research
Published on 01 Apr 2025
Icarisid â…ˇ modulates mitochondrial dynamics for anti-HBV activity
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1544714
- 155 views
Systematic Review
Accepted on 31 Mar 2025
Global Trends in Extended-Spectrum Cephalosporin Resistance in Neisseria gonorrhoeae: A Systematic Review and Meta-Analysis
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1527128
Brief Research Report
Accepted on 31 Mar 2025
Efficacy and safety of antiviral treatments for symptomatic COVID-19 outpatients: network meta-analysis and budget impact analysis
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1537018
Editorial
Published on 31 Mar 2025
Editorial: Emerging and reemerging neglected tropical diseases: epidemiology, transmission, mitigation, and vaccines and chemotherapy advancements
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1545801
- 277 views
Original Research
Published on 31 Mar 2025
The efficacy and safety of ceftazidime/avibactam or polymyxin B based regimens for carbapenem-resistant Pseudomonas aeruginosa infection: a multicenter real-world and propensity score-matched study
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1533952
- 174 views
Original Research
Published on 31 Mar 2025
Appraisal of guidelines and variations in recommendations on drug therapy for invasive aspergillosis prevention and treatment
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1443487
- 147 views
Original Research
Published on 28 Mar 2025
Optimizing fluconazole dosing in acute renal failure patients undergoing continuous renal replacement therapy: A population pharmacokinetic/pharmacodynamic study
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1564070
- 196 views
Original Research
Published on 27 Mar 2025
High vs. low vancomycin therapeutic concentrations in periprosthetic joint infection: A retrospective cohort analysis
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1555276
- 195 views
Original Research
Accepted on 25 Mar 2025
Composite outcome of oral azvudine vs. nirmatrelvir-ritonavir in COVID-19 patients: A retrospective cohort study
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1546787
Original Research
Accepted on 24 Mar 2025
Antibiotic-potentiating efficacy of Rosmarinus officinalis L. to combat planktonic cells, biofilms, and efflux pump activities of extensively drug-resistant Acinetobacter baumannii clinical strains
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1558611
Original Research
Accepted on 24 Mar 2025
Bone loss in young adults with HIV following antiretroviral therapy containing tenofovir disoproxil fumarate regimen using machine learning
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1516013
Original Research
Accepted on 24 Mar 2025
Effectiveness and safety of tenofovir amibufenamide and tenofovir alafenamide in treating elderly patients diagnosed with decompensated hepatitis B cirrhosis: A retrospective cohort study
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1545108
Original Research
Accepted on 21 Mar 2025
Antiviral activity of eicosapentaenoic acid against zika virus and other enveloped viruses
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1564504
- 129 views
Original Research
Published on 20 Mar 2025
The efficacy of polymyxin B in treating stroke-associated pneumonia with carbapenem-resistant Gram-negative bacteria infections: a multicenter real-world study using propensity score matching
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1413563
- 234 views